beroe-ai

HEOR Services
Market, Supplier, Risk and
Competitive Intelligence

best-value

With this purchase you will be subscribed for a 12-month PRO membership to AI Powered Procurement Productivity Suite - Beroe LiVE.Ai

feature

 No Additional Benefits

Subscription Benefits:

  • PRO access to New Beroe LiVE*
  • Category Report with unlimited updates*
  • Supplier Watchlist for 3 suppliers*
  • Supplier Shortlisting Tool*

With this purchase you will be subscribed for a 12-month PRO membership to AI Powered Procurement Productivity Suite - Beroe LiVE.Ai

feature

Manage HEOR Services Category with Ai powered
Procurement Productivity Suite

meet-abi-1

Abi will answer all HEOR Services related
procurement queries with relevant data points

Abi - AI powered digital procurement assistant

discover-market-info

Get up-to-date market and supplier info on HEOR Services to help you build

Intelligence covers market and price outlook, SWOT analysis, demand & supply drivers, engagement models and Procurement best practices

1

Intelligence on category covers the following aspects market outlook, supply market, SWOT analysis, Cost components & Price outlook, Demand and supply drivers, Engagement Models and Procurement Best Practices

manage-risk

Assess Supplier Risk based on key risk and compliance parameters

1

Supplier assessment covers the following parameters Financial Risk, Ethical, Labor, Environmental Compliance, IT Security.

2

Supplier assessment is powered by world’s leading data partners including D&B, CreditSafe, Dow Jones, Refinitiv, Orpheus

discover-supplier

Identify right fit suppliers based on your selection criteria including revenue, capabilities, certification, geography

1

Select suppliers based on industry, country, classification from a database of 4.2 mn suppliers. Get detailed supplier profiles with supplier capabilities, revenue, certifications, risk ratings

assess-category-perforamnce

Benchmark your category performance against peers and the market

1

Measure category performance on 15 key parameters across cost, risk and strategy KPIs

source-market-indices

Get information on key factors affecting your supply

1

Source Macro Data and Market Indices information from leading data sources across these key areas - Labor Rates, Currency, Energy, Country Risk, Trade Flow/Transportation, Port Data, Tariff, Weather and Epidemics

meet-abi-1

Abi will answer all HEOR Services related
procurement queries with relevant data points

Abi - AI powered digital procurement assistant

discover-market-info

Get up-to-date market and supplier info on HEOR Services to help you build

Intelligence covers market and price outlook, SWOT analysis, demand & supply drivers, engagement models and Procurement best practices

1

Intelligence on category covers the following aspects market outlook, supply market, SWOT analysis, Cost components & Price outlook, Demand and supply drivers, Engagement Models and Procurement Best Practices

manage-risk

Assess Supplier Risk based on key risk and compliance parameters

1

Supplier assessment covers the following parameters Financial Risk, Ethical, Labor, Environmental Compliance, IT Security.

2

Supplier assessment is powered by world’s leading data partners including D&B, CreditSafe, Dow Jones, Refinitiv, Orpheus

discover-supplier

Identify right fit suppliers based on your selection criteria including revenue, capabilities, certification, geography

1

Select suppliers based on industry, country, classification from a database of 4.2 mn suppliers. Get detailed supplier profiles with supplier capabilities, revenue, certifications, risk ratings

assess-category-perforamnce

Benchmark your category performance against peers and the market

1

Measure category performance on 15 key parameters across cost, risk and strategy KPIs

source-market-indices

Get information on key factors affecting your supply

1

Source Macro Data and Market Indices information from leading data sources across these key areas - Labor Rates, Currency, Energy, Country Risk, Trade Flow/Transportation, Port Data, Tariff, Weather and Epidemics

Get Beroe LiVE.Ai subscription for your team

17k + companies trust Beroe for their supply market intelligence needs

Check out what’s included in market information for HEOR Services on Beroe LiVE.Ai

Learn More about Beroe LiVE.Ai

Report Coverage

  • HEOR Acquisitions by Geography
  • Mergers and Acqusitions
  • Cost Break-up Analysis

Market Size

CAGR

10-15 Percent

Market Size North America

$312 Mn

Market Size Europe

$ 351 Mn

Market Size Asia Pacific

$ 78 Mn

Table of contents

  1. HEOR Services Executive Summary
  2. Executive Summary
  3. BREXIT Impact Update
  1. HEOR Services Market Analysis
  2. Market Overview
  3. Drivers and Constraints
  4. Market Trends
  5. Porter’s Five Forces Analysis
  6. Outsourcing Adoption Rate
  1. HEOR Services Supply Analysis
  2. Supplier Landscape
  3. Mergers & Acquisitions
  4. Major Suppliers: CROs
  5. Major Suppliers: Non-CROs
  1. HEOR Services IndustryBest Practices
  2. Sourcing Model
  3. Engagement Strategy
  4. Pricing Model
  5. Competitive Intelligence
  1. HEOR Services Quick Reference
  2. Expert Profile

Want a more detailed personalised report?

HEOR Services Market Growth and Global Outlook

  • The HEOR market is growing at a reasonable pace, as the level of outsourcing is high in this category. The market is seen to be heavily consolidating with newer players, like private equity and data analytics company coming into HEOR space. The industry is also witnessing regulations, which require greater real-world evidence and outcome data, which is resulting in the entry of disruptive innovations, like big-data analytics, m-health, bioinformatics, and other patient intelligence technologies
  • Increasing requirement of evidence-based approach as well as increasing demand for outcomes research is fuelled by the increased need for Real-world Evidence (RWE) to demonstrate the value of the drug, driven by regulatory/pricing authorities
  • Increase in the number of drugs in large pharma product pipeline and requirement for orphan drugs to target the unmet medical needs of patients are the key factors increasing the demand to study the market for potential and effective pricing of the product
  • The market is expected to grow further, mainly due to the increasing requirement of evidence-based approach to demonstrate the value of the drug
  • Entry of disruptive technologies, like big data analytics and m-health, are expected to increase in the future, as more HTA organizations around the world require real-world evidence
  • Europe and North America hold the major HEOR market share, 45% and 40% respectively as the availability of experienced market researchers and outcome research-based specialists with proven track records are high within the pharma sector
  • The HEOR market is growing at a reasonable pace, as the level of outsourcing is high in this category. The HEOR market size grew at a CAGR of 10-15% from 2012-2017
  • HEOR and RWE are interlinked as mandatory HTA submission requirement and growing impact of real-world evidence in P&R are the key drivers of outsourcing.

heor-services-global-market-size

  • Increase in the number of drugs in large pharma product pipeline and requirement for orphan drugs to target the unmet medical needs of patients are the key factors increasing the demand to study the market for potential and effective pricing of the product
  • The market is expected to grow further, mainly due to the increasing requirement of evidence-based approach to demonstrate the value of the drug
  • Entry of disruptive technologies, like big data analytics and m-health, are expected to increase in the future, as more HTA organizations around the world require real-world evidenc

Growth Drivers and Constraints

Drivers

  • Real-world evidence and outcome data for reimbursement
  • Increasing demand for showcasing value of the drug
  • Mandatory HTA submission in many countries
  • Pharma being forced to go beyond their comfort zone, like using big-data analytics and m-health technologies, which is driving outsourcing to a large extent
  • Pricing control forcing pharma to invest in substantiating their case (commercial trials)
  • Cost cutting within pharma, leading to increased outsourcing of these services without increasing the head count

Constraints

  • Lack of experience in using genomics, determining sub-group populations for effective outcome demonstration
  • Lack of a standardization of HTA requirements
  • Pharma in nascent stages of contracting in their non-core areas, like m-health and big data
  • Many countries lack mandatory HTA

Outsourcing Adoption Rate

  • Outsourcing is well established and a matured trend in this industry
  • Manpower cost is an issue (for small/mid-size pharma companies)
  •  Novel outsourcing for big data analytics is the new trend. E.g. Pfizer outsourcing real-world evidence data analytics to Optum in 2014
  • Large pharma companies conduct 30 - 50 percent of trial in-house that provide them with evidence/outcome data freely, eliminating a need for third-party players for those specific data
  • The major reason for greater outsourcing in this market is because of varying needs of each study, depending on competition, market, and disease
  • CROs are improving their value proposition by providing HEOR as an integrated service along with clinical trials, which can be as negotiation lever for pharma in a bundle
  • In the future, this category will see entry of disruptive technologies, like big data analytics and m-health, as more HTA organizations around the world require real-world evidence

HEOR Services Top Suppliers

  • IQVIA
  • Xcenda
  • LASER ANALYTICA
  • RTI International

Market Overview

  • The entry of big data analytics, m-health, and other patient analytics tools has been the major trend in the HEOR market. Market is still in infancy with respect to adoption of HEOR services early on in the clinical trials and P&R is the biggest concern for the pharma companies.
  • RWE data demand is increasing over time as players such as insurance companies are demanding huge amount of data defining value and effectiveness of medicines
  • There are three types of service providers: academic, consultants, and CROs. Of the three, consultants and CROs are preferred over academicians, as the latter have little experience in real-world drug development and cannot scale to large trials
  • In the future, as a result of supply base consolidation, pharma companies would engage through strategic partnerships with full-service HEOR and RWE providers rather than specialist for each sub category.

Why You Should Buy This Report

  • The report details the pricing models, supplier landscape and outsourcing adoption rate for the HEOR market. 
  • Information about what is HEOR, HEOR full form, global HEOR market size, emerging markets, drivers, constraints, etc. 
  • Porter’s five force analysis of the HEOR industry
  • It shows the key market trends like novel partnerships, new technologies, full-service providers and emergence of biologics.

Heor Services Frequently Asked Questions

  1. What are the disruptive innovations in the HEOR market?
  2. The HEOR market is rapidly growing and the industry is witnessing regulations that require real-world evidence and data outcome which results in the entry of various disruptive innovations like big-data analytics, m-health, bioinformatics, and other patient intelligence technologies.
  1. Which two countries hold the highest share of the HEOR market and why?
  2. As per Beroe’s study, Europe and North America are known to be the largest shareholders covering 45% and 40% of the HEOR market. It’s primarily because the pharma sector has high availability of experienced market researchers and outcome research-based specialists with a proven track record.
  1. What are the key outsourcing trends prevalent in the HEOR market space? Also, state how much HEOR work gets outsourced on an average?
  2. Following the insights of Beroe’s report, it’s evident that both HEOR and RWE are interlinked as mandatory HTA submission requirements and the growing impact of real-world evidence in P&R are the key drivers of outsourcing. The report also indicates that top pharma companies along with mid-size and specialty pharma companies outsource nearly 75 percent of the HEOR work.
  1. How much HEOR market size is being captured by various continents across the globe?
  2. As per reports, the market size of HEOR is the highest in Europe with a valuation of $351 Mn. Next is North America with a size of $312 Mn, followed by the Asia Pacific region having a valuation of $78 Mn.
  1. Who are the top key suppliers of the HEOR market?
  2. The top ten key players of the HEOR market include the following names: AdRes srl Parexel (Heron) Covance (Medaxial) EPI-Q IMS Health PPDi IQVIA Evidera RTI Health UBC
  1. What’s the most preferred engagement and pricing model for the HEOR market?
  2. As per Beroe’s analysis, the most preferred engagement model w.r.t. the HEOR market is from the supplier’s point of view covering nearly 60 percent of share. Alternative models include FSP and other strategic partnerships. Similarly, the most preferred model for the HEOR services market is by leveraging a fee-for-service model that covers nearly 50 – 60 percent market share. Other models that exist within the industry include the names of FTE and T&M.
  1. What is HEOR and what makes HEOR outsourcing ideal?
  2. HEOR stands for Health Economics and Outcomes Research. The primary factor that boosts the outsourcing trend within the HEOR market is because of the varying needs of each study that depends on competition, market, and disease. Even the CROs are improving their value proposition by providing HEOR as an integrated service in combination with clinical trials.
  1. What is contributing to the growing demand for RWE data within the HEOR industry?
  2. Major insurance companies often demand a huge amount of data to identify the value proposition and effectiveness of the medicines and this contributes to the growth of RWE data within the HEOR industry.
  1. What are the three types of service providers and why is one category preferred over the other?
  2. As per the HEOR analytics report generated by Beroe, there are three types of service providers within the HEOR industry namely – academic, consultants, and CROs. Out of these, CROs and consultants are given preference over academicians because the latter has little experience w.r.t. real-world drug development & isn’t able to scale to large trials.

With this purchase you will be subscribed for a 12-month PRO membership to AI Powered Procurement Productivity Suite - Beroe LiVE.Ai

feature

Complimentary 12-month access to Beroe LiVE

Any more questions?

Get in touch with us quickly and easily.

x

COVID-19: Assess impact on your suppliers and ensure business continuity with Beroe’s WIRE
(World Instant Risk Exposure)